Polpharma Biologics and Tuteur have signed a licensing agreement for biosimilars for autoimmune diseases.

Polpharma Biologics and Tuteur have signed a licensing agreement for biosimilars for autoimmune diseases.

Porpharma Biologics, a biopharmaceutical company specializing in the development and manufacture of biosimilars, today announced a groundbreaking licensing agreement with Argentina-based Tuteur. Under this strategic partnership, Tuteur will acquire exclusive…

Read MorePolpharma Biologics and Tuteur have signed a licensing agreement for biosimilars for autoimmune diseases.
QAD Redzone Releases New CFO Guide to AI in Manufacturing, Challenging Industry to Focus on Financial Outcomes Over AI Hype

QAD | Redzone Releases New CFO Guide to AI in Manufacturing, Challenging Industry to Focus on Financial Outcomes Over AI Hype

QAD | Redzone, the company delivering the leading manufacturing platform, powered by Agentic AI that executes work and decisions across the business, from the shop floor to the top floor, announced the…

Read MoreQAD | Redzone Releases New CFO Guide to AI in Manufacturing, Challenging Industry to Focus on Financial Outcomes Over AI Hype